FDA Workshop: Clinical Trial Design for Non-Muscle Invasive Bladder Cancer (NMIBC) - 11/18/2021

The U.S. Food and Drug Administration (FDA) Oncology Center of Excellence (OCE) and Center for Drug Evaluation and Research (CDER) welcome you to this FDA Virtual Public Workshop: Clinical Trial Design for Non-Muscle Invasive Bladder Cancer (NMIBC).

Source: FDA Center for Drug Evaluation and Research - What's New - January 18, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news